<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02027883</url>
  </required_header>
  <id_info>
    <org_study_id>VF Induction</org_study_id>
    <nct_id>NCT02027883</nct_id>
  </id_info>
  <brief_title>Comparison of VF Induction Techniques During Medtronic ICD Implant (VF) (ICD)</brief_title>
  <acronym>VF</acronym>
  <official_title>Comparison of Ventricular Fibrillation Induction Techniques During Medtronic Implantable Cardioverter Defibrillator Implant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>James Merrill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Wellmont CVA Heart Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      As the indications for Implantable Cardioverter Defibrillator implantation expand, minimizing
      implant time is critical. Also, patients receiving biventricular ICDs are sometimes more
      unstable and minimization of sedation time is crucial. Multiple induction attempts, with a
      1-Joule shock, can cause disruption in lead position. Therefore limiting the number of
      attempts will allow for better lead stability throughout the procedure and a more
      straightforward implant process.

      Investigator proposes a detailed documentation of success rates from various Ventriculart
      Fibrillation induction methods during implant of Medtronic defibrillation capable devices.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our clinical experience has found that attempts to induce patients receiving ICDs at implant
      using the nominal Medtronic T-shock settings are not always effective at inducing ventricular
      fibrillation. When this results, a change to the parameters for T-shock is made before
      reattempting to induce ventricular fibrillation in patients undergoing ICD implantation.

      Another available induction method is 50 Hz Burst. &quot;The 50 Hz Burst induction is designed to
      induce VF by delivering a rapid burst of pacing pulses. The amplitude and pulse width of
      these pulses are selectable, but the pacing interval is fixed at 20 ms.&quot;2 If multiple
      attempts using the T-shock method are unsuccessful, 50 Hz Burst provides an additional method
      for inducing ventricular fibrillation. It is a less desirable method since it can result in
      very fine VF that is difficult to identify the initiation of possibly resulting in longer
      times in VF causing higher defibrillation threshold or in undersensing due to the fine nature
      of the rhythm.

      T-shock has been found to be a fast and reliable method for inducing ventricular fibrillation
      in ICD implants. Greater success of inducing ventricular fibrillation using the T-shock
      method has been found when the energy of the T-shock was higher and the coupling interval was
      shorter. In addition, increasing the shock strength increases the window of vulnerability.
      For the T-shock method to be most efficient, initial success at inducing ventricular
      fibrillation, and therefore a reduced number of attempts, is important. This requires a
      better understanding of the optimal programmed settings for the initial T-shock induction
      attempt.

      Moreover, in recent years, ICD indications have grown to include primary prevention patients.
      These patients may have different vulnerable periods than patients previously evaluated to
      develop Medtronic nominal settings.

      Our clinical experience has found that the nominal T-shock settings are only effective at
      inducing ventricular fibrillation approximately seventy-five percent of the time. However, a
      detailed collection of success rates has not been performed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sustained Ventricular Fibrillation</measure>
    <time_frame>2 hours</time_frame>
    <description>The primary endpoint is the successful induction of sustained ventricular fibrillation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Factors</measure>
    <time_frame>2 hours</time_frame>
    <description>Determine if any pre-implant patient demographics are factors impacting T-shock success according to parameter settings.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Safety Monitoring</measure>
    <time_frame>2 hours</time_frame>
    <description>Number of participants that were monitored for safety issues, including increased heart rate, blood pressure, decreased oximetry levels, and stable rhythm during the entire procedure.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>Nominal Parameter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nominal T shock setting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental Parameter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Educated T shock setting</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nominal T shock setting</intervention_name>
    <description>Nominal Parameter Set 1 Programming Values for EnTrust</description>
    <arm_group_label>Nominal Parameter</arm_group_label>
    <other_name>Medtronic ICDs</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Educated T shock setting</intervention_name>
    <description>Experimental Parameter Set 2 Programming Values</description>
    <arm_group_label>Experimental Parameter</arm_group_label>
    <other_name>Medtronic ICDs</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients undergoing Medtronic ICD or Cardiac Resynchronization
             Therapy-Defibrillator implant (initial implant or generator replacement) will be
             included.

        Exclusion Criteria:

          -  Any patient who is medically unstable and testing is deemed unsafe by physician will
             be excluded from this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Wellmont CVA Heart Institute</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bardy G, Mehra R, Johnson G, Kudenchuk P, Dolack G, Poole J, Hofer B: Low energy pulsing on the T-wave: A new programming method for intentional, device mediated induction of ventricular fibrillation for defibrillation testing. PACE 15(4, Pt II): 562, 1992.</citation>
  </reference>
  <reference>
    <citation>Bhandari AK, Isber N, Estioko M, Ziccardi T, Cannom DS, Park Y, Lerman RD, Prejean C, Sun GW. Efficacy of low-energy T wave shocks for induction of ventricular fibrillation in patients with implantable cardioverter defibrillators. J Electrocardiol. 1998 Jan;31(1):31-7.</citation>
    <PMID>9533375</PMID>
  </reference>
  <reference>
    <citation>Marquis DR Reference Manual, Medtronic, Inc.</citation>
  </reference>
  <reference>
    <citation>Mitchell L, Yee R, Talajic M, Newman D, Sheldon R, Kerr C, Kus T, Boyle A, Canadian Jewel PCD Investigators: Low-energy, T-wave synchronous, interval shock for rapid, reliable ventricular fibrillation induction by an implantable cardioverter defibrllattor. PACE, 17(4, Pt II): 851, 1994.</citation>
  </reference>
  <reference>
    <citation>Swartz J, Stanton M, DeGroot P, Mehra R: Influence of T-wave shock energy on ventricular fibrillation vulnerability in humans. JACC 1995 Conference Abstracts: 214A, 1995.</citation>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 31, 2013</study_first_submitted>
  <study_first_submitted_qc>January 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2014</study_first_posted>
  <results_first_submitted>June 24, 2014</results_first_submitted>
  <results_first_submitted_qc>December 29, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 30, 2014</results_first_posted>
  <last_update_submitted>April 23, 2018</last_update_submitted>
  <last_update_submitted_qc>April 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Wellmont CVA Heart Institute</investigator_affiliation>
    <investigator_full_name>James Merrill</investigator_full_name>
    <investigator_title>James Merrill, MD, FACC</investigator_title>
  </responsible_party>
  <keyword>Defibrillators</keyword>
  <keyword>Ventricular Fibrillation Induction Testing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Nominal Parameter</title>
          <description>Nominal T shock setting
Nominal T shock setting: Nominal Parameter Set 1 Programming Values for EnTrust</description>
        </group>
        <group group_id="P2">
          <title>Experimental Parameter</title>
          <description>Educated T shock setting
Educated T shock setting: Experimental Parameter Set 2 Programming Values</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Nominal Parameter</title>
          <description>Nominal T shock setting
Nominal T shock setting: Nominal Parameter Set 1 Programming Values for EnTrust</description>
        </group>
        <group group_id="B2">
          <title>Experimental Parameter</title>
          <description>Educated T shock setting
Educated T shock setting: Experimental Parameter Set 2 Programming Values</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.82" spread="13.68403"/>
                    <measurement group_id="B2" value="66.68" spread="10.51809"/>
                    <measurement group_id="B3" value="64.25" spread="12.38554"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>VF Induction amount of participants</title>
          <description>Number of subjects that participated in the VF induction study protocol.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Sustained Ventricular Fibrillation</title>
        <description>The primary endpoint is the successful induction of sustained ventricular fibrillation.</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nominal Parameter</title>
            <description>Nominal T shock setting
Nominal T shock setting: Nominal Parameter Set 1 Programming Values for EnTrust</description>
          </group>
          <group group_id="O2">
            <title>Experimental Parameter</title>
            <description>Educated T shock setting
Educated T shock setting: Experimental Parameter Set 2 Programming Values</description>
          </group>
        </group_list>
        <measure>
          <title>Sustained Ventricular Fibrillation</title>
          <description>The primary endpoint is the successful induction of sustained ventricular fibrillation.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Factors</title>
        <description>Determine if any pre-implant patient demographics are factors impacting T-shock success according to parameter settings.</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nominal Parameter</title>
            <description>Nominal T shock setting: Nominal Parameter Set 1 Programming Values for EnTrust.</description>
          </group>
          <group group_id="O2">
            <title>Experimental Parameter</title>
            <description>Educated T shock setting: Experimental Parameter Set 2 Programming Values.</description>
          </group>
        </group_list>
        <measure>
          <title>Factors</title>
          <description>Determine if any pre-implant patient demographics are factors impacting T-shock success according to parameter settings.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Successful Male Participants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Successful Female participants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unsuccessful Male Participants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unsuccessful Female Participants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Safety Monitoring</title>
        <description>Number of participants that were monitored for safety issues, including increased heart rate, blood pressure, decreased oximetry levels, and stable rhythm during the entire procedure.</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nominal Parameter</title>
            <description>Nominal T shock setting
Nominal T shock setting: Nominal Parameter Set 1 Programming Values for EnTrust
The standard T-Shock method was successful in 76% of the patients. 38 out of 50 patients Ventricular Fibrillation was induced with the nominal T shock method. In contrast, 87 % or 13 out of 15 that failed to induce Ventricular Fibrillation using the educated T-Shock method was successfully induced when crossed to the nominal T-shock method.</description>
          </group>
          <group group_id="O2">
            <title>Experimental Parameter</title>
            <description>Educated T shock setting
Educated T shock setting: Experimental Parameter Set 2 Programming Values
The educated T shock setting method was successful in 70% of the patients. 35 out of 50 patients Ventricular Fibrillation was induced with the educated T- shock method. Of the 12 patients that were did not have Ventricular fibrillation induced with the nominal T-shock method, they were all successfully induced with the educated T-Shock method.</description>
          </group>
        </group_list>
        <measure>
          <title>Safety Monitoring</title>
          <description>Number of participants that were monitored for safety issues, including increased heart rate, blood pressure, decreased oximetry levels, and stable rhythm during the entire procedure.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The patient's were observed for adverse events from the time of consent to the time they met the primary endpoint.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Nominal Parameter</title>
          <description>Nominal T shock setting
Nominal T shock setting: Nominal Parameter Set 1 Programming Values for EnTrust</description>
        </group>
        <group group_id="E2">
          <title>Experimental Parameter</title>
          <description>Educated T shock setting
Educated T shock setting: Experimental Parameter Set 2 Programming Values</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Terrie Walker, Director of Clinical Research</name_or_title>
      <organization>Wellmont CVA Heart Institute</organization>
      <phone>423-230-5643</phone>
      <email>twalker@mycva.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

